INS and metabolic syndrome: Data from clinical investigations of FMT have shown that after 6 weeks of FMT intervention, lean-donor FMT can help MetS participants lose weight (including visceral fat), improve insulin resistance and peripheral insulin sensitivity, and lower subjects' blood pressure (Mocanu et al., 2021).